.png)
A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with Alcohol Use Disorder (AUD).
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
LOUISVILLE, Colo., March 17, 2026 /PRNewswire/ — Global Healthcare Exchange (GHX) today announced the recipients of its 2025 Supply Chains of Distinction Award, recognizing hospitals and health systems across North America that achieved top-tier supply […]
Michael Kilmer, who had served as executive director of the Aurora-based system, is working on detail for another regional system. Click here to view original post
Sujatha Jagannathan, PhD, shuffles 11 Petri dishes around a table, sorting them in groups according to how fast the yeast strains grew in the cultures. Her student researchers look on, scanning the culture dishes for […]
Copyright © 2026 Biotech Networks
